부산대학교 도서관

de Vries, E. G. E.; Garralda, E.; Litiere, S.

ANNALS OF ONCOLOGY; MAR 2026, 37 3, p286-p288, 3p.

Turner, NC; Balmaña, J; Poncet, C; Goulioti, T; Tryfonidis, K; Honkoop, AH; Zoppoli, G; Razis, E; Johannsson, OT; Colleoni, M; Tutt, AN; Audeh, W; Ignatiadis, M; Mailliez, A; Trédan, O; Musolino, A; Vuylsteke, P; Juan-Fita, MJ; Macpherson, IRJ; Kaufman, B; Manso, L; Goldstein, LJ; Ellard, SL; Láng, I; Jen, KY; Adam, V; Litière, S; Erban, J; Cameron, DA; BRAVO Steering Committee and the BRAVO investigators

Clin Cancer Res
Clinical cancer research, 27 (20
2021, ' Niraparib for advanced breast cancer with germline BRCA1 and BRCA2 mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO study ', Clinical Cancer Research . https://doi.org/10.1158/1078-0432.CCR-21-0310

DUVIGNEAUD, P.; SMET, S. DENAEYER-DE; MARBAISE, J.-L.

Bulletin de la Société Royale de Botanique de Belgique / Bulletin van de Koninklijke Belgische Botanische Vereniging, 1969 Jan 01. 102(2), 339-354.

Casali, P.G. ; Le Cesne, A. ; Velasco, A.P. ; Kotasek, D. ; Rutkowski, P. ; Hohenberger, P. ; Fumagalli, E. ; Judson, I.R. ; Italiano, A. ; Gelderblom, H. ; Penel, N. ; Hartmann, J.T. ; Duffaud, F. ; Goldstein, D. ; Martin-Broto, J. ; Gronchi, A. ; Wardelmann, E. ; Marréaud, S. ; Zalcberg, J.R. ; Litière, S. ; Blay, J.-Y.

In Annals of Oncology April 2021 32(4):533-541

Ignatiadis, M. ; Litière, S. ; Rothe, F. ; Riethdorf, S. ; Proudhon, C. ; Fehm, T. ; Aalders, K. ; Forstbauer, H. ; Fasching, P.A. ; Brain, E. ; Vuylsteke, P. ; Guardiola, E. ; Lorenz, R. ; Pantel, K. ; Tryfonidis, K. ; Janni, W. ; Piccart, M. ; Sotiriou, C. ; Rack, B. ; Pierga, J.-Y.

In Annals of Oncology August 2018 29(8):1777-1783

Hobor S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.; Skrzypski M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.; Department of Oncology and Radiotherapy, Medical University of Gdańsk, ul. Mariana Smoluchowskiego 17, 80-214, Gdańsk, Poland.; Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.; Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Markovets A; Oncology Data Science, Oncology R&D, AstraZeneca, Boston, MA, USA.; Dry JR; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Brown AP; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; van der Aart J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; van den Bos H; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.; Spierings D; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.; Oukrif D; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK.; Novelli M; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK.; Chakrabarti T; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Rabinowitz AH; Furlong Laboratory, EMBL Meyerhofstraße 1, 69117, Heidelberg, Germany.; Ait Hassou L; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Litière S; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK.; Kerr DL; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Tan L; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Kelly G; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Renshaw MJ; Advanced Light Microscopy, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Venkatesan S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Wu W; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Chmielecki J; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Barrett C; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Chew SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Blakely CM; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; de Bruin EC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.; Vousden KH; p53 and Metabolism Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Bivona TG; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, USA.; Hynds RE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. n.kanu@ucl.ac.uk.; Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. s.zaccaria@ucl.ac.uk.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk.; Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Eva.Gronroos@crick.ac.uk.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Charles.Swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK. Charles.Swanton@crick.ac.uk.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

E. E. A. P. Mulder; K. de Joode; S. Litière; A. J. ten Tije; K. P. M. Suijkerbuijk; M. J. Boers-Sonderen; G. A. P. Hospers; J. W. B. de Groot; A. J. M. van den Eertwegh; M. J. B. Aarts; D. Piersma; R. S. van Rijn; E. Kapiteijn; G. Vreugdenhil; F. W. P. J. van den Berkmortel; E. Oomen-de Hoop; M. G. Franken; B. Ryll; P. Rutkowski; S. Sleijfer; J. B. A. G. Haanen; A. A. M. van der Veldt

BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)

Kantidakis, G.; Putter, H.; Litière, S.; Fiocco, M.

BMC Med Res Methodol
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-14 (2023)

Morfouace, M. ; Hewitt, S.M. ; Salgado, R. ; Hartmann, K. ; Litiere, S. ; Tejpar, S. ; Golfinopoulos, V. ; Lively, T. ; Thurin, M. ; Conley, B. ; Lacombe, D.

In Seminars in Cancer Biology October 2018 52 Part 2:158-165

Seront E; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Electronic address: emmanuel.seront@saintluc.uclouvain.be.; Bsilat M; Department of Urology, Clinique Saint-Jean, Brussels, Belgium.; Goffin K; Department of Nuclear Medicine, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Govaerts AS; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Litière S; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Cabrieto J; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Dhondt B; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Tombal B; Insitut de Recherche Clinique, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Albiges L; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Touati, N. ; Schöffski, P. ; Litière, S. ; Judson, I. ; Sleijfer, S. ; van der Graaf, W.T. ; Italiano, A. ; Isambert, N. ; Gil, T. ; Blay, J.Y. ; Stark, D. ; Brodowicz, T. ; Marréaud, S. ; Gronchi, A.

In Clinical Oncology July 2018 30(7):448-454

Callegaro D; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Tinè G; Department of Data Science and Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oppong FB; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Nzokirantevye A; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Litière S; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Percio S; Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Carenzo A; Integrated Biology of Rare Tumors Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; De Cecco L; Integrated Biology of Rare Tumors Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Chibon F; Oncogenesis of Sarcomas, INSERM UMR1037, Cancer Research Centre of Toulouse, Toulouse, France.; Brich S; Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Bertolotti A; Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Collini P; Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Frezza AM; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Huang P; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Haas R; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Radiotherapy, The Leiden University Medical Center, Leiden, the Netherlands.; Bonvalot S; Department of Surgical Oncology, Institut Curie, Paris, France.; van Houdt WJ; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Miceli R; Department of Data Science and Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pasquali S; Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Verschoor, A.J. ; Litière, S. ; Marréaud, S. ; Judson, I. ; Toulmonde, M. ; Wardelmann, E. ; van der Graaf, W.T. ; Le Cesne, A. ; Gronchi, A. ; Gelderblom, H.

In European Journal of Cancer May 2018 94:187-198

C. Dittrich; M. Kosty; S. Jezdic; D. Pyle; R. Berardi; J. Bergh; N. El Saghir; J.-P. Lotz; P. Österlund; N. Pavlidis; G. Purkalne; Hetty Carraway; Julia Lee Close; Jill Gilbert; Carsten Bokemeyer; Andrés Cervantes; Yuichiro Ohe; Miklos Pless; Keith McGregor; Katharine Fumassoli; Roberta Candiani; Gracemarie Bricalli; Tanya Kenny; Nicola Latino; Marina Cogo; Vanessa Pavinato; Vanessa Marchesi; Ahmad Awada; Susana Banerjee; Smita Bhatia; Jan Bogaerts; Jan Buckner; Fatima Cardoso; Paolo Casali; Edward Chu; Bertrand Coiffier; Roisin Connolly; Sarah Coupland; Luigi De Petris; Maria De Santis; Elisabeth G.E. de Vries; Don S. Dizon; Jennifer Duff; Linda R. Duska; Alexandru Eniu; Marc Ernstoff; Enriqueta Felip; Martin F. Fey; Nicolas Girard; Andor W.J.M. Glaudemans; Priya K. Gopalan; Axel Grothey; Stephen M. Hahn; Diana Hanna; Christian Herold; Jørn Herrstedt; Krisztian Homicsko; Dennie V. Jones; Lorenz Jost; Ulrich Keilholz; Saad Khan; Alexander Kiss; Claus-Henning Köhne; Rainer Kunstfeld; Heinz-Josef Lenz; Stuart Lichtman; Lisa Licitra; Thomas Lion; Saskia Litière; Lifang Liu; Patrick J. Loehrer; Merry Jennifer Markham; Ben Markman; Marius Mayerhoefer; Johannes G. Meran; Olivier Michielin; Elizabeth Charlotte Moser; Giannis Mountzios; Timothy Moynihan; Torsten Nielsen; Kjell Öberg; Antonio Palumbo; Fedro Alessandro Peccatori; Michael Pfeilstöcker; Chandrajit Raut; Scot C. Remick; Mark Robson; Piotr Rutkowski; Roberto Salgado; Lidia Schapira; Eva Schernhammer; Martin Schlumberger; Hans-Joachim Schmoll; Lowell Schnipper; Cristiana Sessa; Charles L. Shapiro; Julie Steele; Cora N. Sternberg; Friedrich Stiefel; Florian Strasser; Roger Stupp; Richard Sullivan; Josep Tabernero; Luzia Travado; Marcel Verheij; Emile Voest; Everett Vokes; Jamie Von Roenn; Jeffrey S. Weber; Hans Wildiers; Yosef Yarden

Ann Oncol
Annals of oncology, vol. 27, no. 8, pp. 1378-1381
Annals of Oncology

Cardoso, F. ; Bartlett, J.M.S. ; Slaets, L. ; van Deurzen, C.H.M. ; van Leeuwen-Stok, E. ; Porter, P. ; Linderholm, B. ; Hedenfalk, I. ; Schröder, C. ; Martens, J. ; Bayani, J. ; van Asperen, C. ; Murray, M. ; Hudis, C. ; Middleton, L. ; Vermeij, J. ; Punie, K. ; Fraser, J. ; Nowaczyk, M. ; Rubio, I.T. ; Aebi, S. ; Kelly, C. ; Ruddy, K.J. ; Winer, E. ; Nilsson, C. ; Lago, L. Dal ; Korde, L. ; Benstead, K. ; Bogler, O. ; Goulioti, T. ; Peric, A. ; Litière, S. ; Aalders, K.C. ; Poncet, C. ; Tryfonidis, K. ; Giordano, S.H.

In Annals of Oncology February 2018 29(2):405-417

Savina, M; Litière, S; Italiano, A; Burzykowski, T; Bonnetain, F; Gourgou, S; Rondeau, V; Blay, J-Y; Cousin, S; Duffaud, F; Gelderblom, H; Gronchi, A; Judson, I; Le Cesne, A; Lorigan, P; Maurel, J; van der Graaf, W; Verweij, J; Mathoulin-Pélissier, S; Bellera, C

Oncotarget
Oncotarget, 9, 77, pp. 34617-34627

Younger, E; Litière, S; Le Cesne, A; Mir, O; Gelderblom, H; Italiano, A; Marreaud, S; Jones, RL; Gronchi, A; van der Graaf, WTA

Oncologist, 23, 10, pp. 1250-1259
Oncologist

Lawlor, A.; Van Hemelrijck, M.; MacLennan, S.; Bogaerts, J.; Litiere, S.; Golfinopoulos, V.; Lehmann, J.; Szturz, P.; Williamson, P.

In: Trials. (Trials, December 2025, 26(1))

Leboulleux S; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.; Litière S; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU-Leuven (KU), Leuven, Leuven, Belgium.; Godbert Y; Department of Oncology and Department of Nuclear Medicine, Institut Bergonie, Bordeaux, France.; Rodien P; Department of Endocrinology, Diabetology and Nutrition, Angers University Hospital Center (CHU) d'Angers, Angers, France.; Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.; Salvatore D; Department of Public Health, Azienda Ospedaliera Universitaria 'Federico II', Napoli, Italy.; Zanetta S; Department of Medical Oncology, Centre Georges-Francois-Leclerc, Dijon, France.; Capdevila J; Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark.; De La Fouchardiere C; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Lalami Y; Institut Jules Bordet/Hôpital Universitaire de Bruxelles (HUB), Anderlecht, Belgium.; Bardet S; Department of Nuclear Medicine and Thyroid Unit, Centre Francois Baclesse, Caen, France.; Cornélis F; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Dedecjus M; Maria Skłodowska Curie's National Institute of Oncology, National Research Institute, Warsaw, Poland.; Links T; University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Sents W; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Schlumberger M; Gustave Roussy, Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France.; Locati DL; Head and Neck Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.; Newbold K; Head and Neck Unit, Royal Marsden Hospital Sutton Surrey, Surrey, United Kingdom.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

Ecologia mediterranea 7(2):13-25